Logo image of RCLF

ROSECLIFF ACQUISITION CORP-A (RCLF) Stock Fundamental Analysis

NASDAQ:RCLF - Nasdaq - US77732R1032 - Common Stock - Currency: USD

11.57  -0.64 (-5.24%)

After market: 11.75 +0.18 (+1.56%)

Fundamental Rating

0

RCLF gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. RCLF has a bad profitability rating. Also its financial health evaluation is rather negative. RCLF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RCLF has reported negative net income.
In the past year RCLF has reported a negative cash flow from operations.
RCLF Yearly Net Income VS EBIT VS OCF VS FCFRCLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 3.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCLF Yearly ROA, ROE, ROICRCLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 100 -100

1.3 Margins

RCLF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCLF Yearly Profit, Operating, Gross MarginsRCLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for RCLF has been reduced compared to 1 year ago.
There is no outstanding debt for RCLF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RCLF Yearly Shares OutstandingRCLF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M
RCLF Yearly Total Debt VS Total AssetsRCLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

RCLF has an Altman-Z score of -3.31. This is a bad value and indicates that RCLF is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.31
ROIC/WACCN/A
WACCN/A
RCLF Yearly LT Debt VS Equity VS FCFRCLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

RCLF has a Current Ratio of 0.11. This is a bad value and indicates that RCLF is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.11 indicates that RCLF may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
RCLF Yearly Current Assets VS Current LiabilitesRCLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RCLF have decreased strongly by -236.17% in the last year.
EPS 1Y (TTM)-236.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-430.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCLF Yearly Revenue VS EstimatesRCLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
RCLF Yearly EPS VS EstimatesRCLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCLF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCLF Price Earnings VS Forward Price EarningsRCLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCLF Per share dataRCLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RCLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROSECLIFF ACQUISITION CORP-A

NASDAQ:RCLF (9/11/2023, 8:16:13 PM)

After market: 11.75 +0.18 (+1.56%)

11.57

-0.64 (-5.24%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.23%
Inst Owner Change-8.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS-1.42
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -3.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-430.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.43%
OCF growth 3YN/A
OCF growth 5YN/A